Does hemodialysis affect clopidogrel resistance as measured by verifyNow® P2Y12 test?

American Journal of Cardiology

Volumn 107, Issue 7, 2011, Pages 1103-1104

  Geara, Abdallah S ^a   Ayoub, Isabelle ^a   Abi Rached, Jacques ^a   Siddique, Muhammad N ^a   Ghimire, Pratima ^a   El Sayegh, Suzanne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR;

ANALYTICAL EQUIPMENT; BLEEDING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KOREA; LETTER; MALE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RISK ASSESSMENT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS;

ANGIOPLASTY, BALLOON, CORONARY; BLOOD PLATELETS; DRUG RESISTANCE; HUMANS; KIDNEY FAILURE, CHRONIC; LONG-TERM CARE; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; RENAL DIALYSIS; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 79952749944     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.01.003     Document Type: Letter

References (8)

1. D.R. Rios, M.G. Carvalho, B.A. Lwaleed, A.C. Simoes e Silva, K.B. Borges, and L.M. Dusse Hemostatic changes in patients with end stage renal disease undergoing hemodialysis Clin Chim Acta 411 2010 135 139
2. J.S. Kaufman, T.Z. O'Connor, J.H. Zhang, R.E. Cronin, L.D. Fiore, M.B. Ganz, D.S. Goldfarb, P.N. Peduzzi Veterans Affairs Cooperative Study Group on Hemodialysis Access Graft Thrombosis Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis J Am Soc Nephrol 14 2003 2313 2321 (Pubitemid 37052378)
3. K.E. Chan, J.M. Lazarus, R. Thadhani, and R.M. Hakim Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients J Am Soc Nephrol 20 2009 872 881
4. T. Cuisset, and G. Cayla Aspirin and clopidogrel resistance: should we worry about? Minerva Med 101 2010 35 47
5. S.H. Park, W. Kim, C.S. Park, W.Y. Kang, and S.H. Hwang A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure Am J Cardiol 104 2009 1292 1295
6. J.A. Jakubowski, Y.G. Li, D.S. Small, C.D. Payne, M.E. Tomlin, J. Luo, and K.J. Winters A Comparison of VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis J Cardiovasc Pharmacol 56 2010 29 37
7. A. Aggarwal, S.S. Kabbani, J.M. Rimmer, F.J. Gennari, D.J. Taatjes, B.E. Sobel, and D.J. Schneider Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk Am J Kidney Dis 40 2002 315 322 (Pubitemid 34827649)
8. V. Sirolli, L. Strizzi, S. Di Stante, I. Robuffo, A. Procopio, and M. Bonomini Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis Thromb Haemost 86 2001 834 839 (Pubitemid 32834194)